2211-57-6 | N-Benzylguanidine

Packsize	Purity	Availability	Price	Discounted Price
250mg	95%	in stock	$93.00	$65.00
1g	95%	in stock	$137.00	$96.00
5g	95%	in stock	$448.00	$314.00
10g	95%	in stock	$758.00	$531.00

Description

• Catalog Number: AD26584
• Chemical Name: N-Benzylguanidine
• CAS Number: 2211-57-6
• Molecular Formula: C10H15N3O2
• Molecular Weight: 209.245
• MDL Number: MFCD09864972
• SMILES: NC(=N)[NH2+]Cc1ccccc1.[O-]C(=O)C
• NSC Number: 227970

Computed Properties

• Complexity: 132
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 11
• Hydrogen Bond Acceptor Count: 1
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 2
• XLogP3: 0.3

Literature

• Sensitive detection of intracellular sumoylation via SNAP tag-mediated translation and RNA polymerase-based amplification.

  Analytical chemistry 20120207

• Relative contributions of mitochondria and NADPH oxidase to deoxycorticosterone acetate-salt hypertension in mice.

  Kidney international 20110701

• Simple preparation of pacific cod trypsin for enzymatic Peptide synthesis.

  Journal of amino acids 20110101

• Multiple mechanisms for hydrogen peroxide-induced apoptosis.

  Annals of the New York Academy of Sciences 20090801

• Benzylguanidines and other galegine analogues inducing weight loss in mice.

  Journal of medicinal chemistry 20090611

• Transcranial sonography of the substantia nigra and MIBG myocardial scintigraphy: complementary role in the diagnosis of Parkinson's disease.

  Parkinsonism & related disorders 20090501

• Small, potent, and selective diaryl phosphonate inhibitors for urokinase-type plasminogen activator with in vivo antimetastatic properties.

  Journal of medicinal chemistry 20071227

• Amine-guanidine switch: a promising approach to improve DNA binding and antiproliferative activities.

  Journal of medicinal chemistry 20071227

• Effects of tumour acidification with glucose+MIBG on the spontaneous metastatic potential of two murine cell lines.

  British journal of cancer 20040504

• Tumor oxygenation and acidification are increased in melanoma xenografts after exposure to hyperglycemia and meta-iodo-benzylguanidine.

  Radiation research 20030301

• Characterization of sabiporide, a new specific NHE-1 inhibitor exhibiting slow dissociation kinetics and cardioprotective effects.

  European journal of pharmacology 20030117

• Lentiviral transduction of P140K MGMT into human CD34(+) hematopoietic progenitors at low multiplicity of infection confers significant resistance to BG/BCNU and allows selection in vitro.

  Molecular therapy : the journal of the American Society of Gene Therapy 20020401

• Biological evaluation of ring- and side-chain-substituted m-iodobenzylguanidine analogues.

  Bioconjugate chemistry 20010101

• Chum salmon trypsin-catalyzed preferential formation of peptides containing D-amino acid.

  Amino acids 20010101